Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook

Go back to Fate Therapeutics Reports Fourth Quarter 2019 Financial Results and Operational Progress with 2020 Outlook
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.15 --0 (-0%)
Previous Close $2.15    52 Week High $4.76 
Open $2.15    52 Week Low $1.46 
Day High $2.15    P/E N/A 
Day Low $2.15    EPS $-1.91 
Volume 76,134